Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Sean Carrick | President, CEO, Secretary & Director | 252k | -- | 1968 |
| Mr. Lowell Holden | CFO, Chief Accounting Officer & Director | 180k | -- | 1943 |
| Dr. Mark C. Glassy Ph.D. | Founder | 43k | -- | 1952 |
| Dr. Navpaul Singh M.D. | Chief Medical Consultant | -- | -- | -- |
Nascent Biotech, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.
Corporate Governance
Upcoming Events
January 31, 2025 at 10:59 AM UTC - February 9, 2025 at 12:00 PM UTC
Nascent Biotech, Inc. Earnings Date
Recent Events
April 5, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission